Results 71 to 80 of about 238,614 (342)

A Functional Interleukin-1 Receptor Antagonist Polymorphism Influences Atherosclerosis Development The Interleukin-1.BETA.:Interleukin-1 Receptor Antagonist Balance in Atherosclerosis

open access: yesCirculation Journal, 2009
Interleukin (IL)-beta plays a central role in inflammation and atherosclerosis, but levels of IL-1beta, its natural antagonist, IL-1Ra, and their balance in human atherosclerotic lesions, are unknown. Knowledge of protein levels in atherosclerosis and the influence of a functional IL-1Ra polymorphism would increase the understanding of atherosclerosis ...
Peder S. Olofsson   +8 more
openaire   +4 more sources

Interleukin Gene Marker for Febrile Seizures

open access: yesPediatric Neurology Briefs, 2002
The use of polymorphisms for interleukin IB (IL-1B) exon 5 and interleukin 1 receptor antagonist (IL-1Ra) as markers of susceptibility to febrile seizures was evaluated in Taiwanese children (group 1: 51 with febrile convulsions and group 2: 83 normal ...
J Gordon Millichap
doaj   +1 more source

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

open access: yesMolecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park   +6 more
wiley   +1 more source

A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke

open access: yesJournal of Cerebral Blood Flow and Metabolism, 2015
Stroke represents a global challenge and is a leading cause of permanent disability worldwide. Despite much effort, translation of research findings to clinical benefit has not yet been successful. Failure of neuroprotection trials is considered, in part,
S. Maysami   +14 more
semanticscholar   +1 more source

Cannabinoid signalling in TNF-alpha induced IL-8 release [PDF]

open access: yes, 2006
Original article can be found at: http://www.sciencedirect.com/science/journal/00142999 Copyright Elsevier B.V.
Baydoun, A. R.   +4 more
core   +1 more source

Use of Anakinra in Patients with Cryopyrin-Associated Periodic Syndromes and Other Autoinflammatory Diseases

open access: yesВопросы современной педиатрии, 2016
The article describes the main autoinflammatory syndromes as well as the key role of interleukin (IL) 1 in the pathogenesis of these diseases. It also presents the data on the experience of anakinra using (soluble IL-1 receptor antagonist) as well as the
Mikhail M. Kostik
doaj   +1 more source

Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse. [PDF]

open access: yesPLoS ONE, 2011
Healing after acute myocardial infarction (AMI) is characterized by an intense inflammatory response and increased Interleukin-1 (IL-1) tissue activity. Genetically engineered mice lacking the IL-1 receptor (IL-1R1-/-, not responsive to IL-1) or the IL-1
Antonio Abbate   +7 more
doaj   +1 more source

Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study

open access: yesFrontiers in Immunology, 2023
BackgroundThe interleukin-1 pathway has been linked to pancreatic diseases. We applied the Mendelian randomization approach to explore whether higher interleukin-1 receptor antagonist (IL-1RA) levels reduce the risk of acute and chronic pancreatitis and ...
Shuai Yuan   +7 more
doaj   +1 more source

CircCCNB1 inhibits vasculogenic mimicry by sequestering NF90 to promote miR‐15b‐5p and miR‐7‐1‐3p processing in nasopharyngeal carcinoma

open access: yesMolecular Oncology, EarlyView.
CircCCNB1 expression is down‐regulated in nasopharyngeal carcinoma (NPC); thus, less NF90 protein is bound to circCCNB1 and more binds to pri‐miRNAs, blocking their (pri‐miRNAs) binding to DGCR8 and inhibiting the processing and generation of miR‐15b‐5p/miR‐7‐1‐3p. Furthermore, decreased miR‐15b‐5p/miR‐7‐1‐3p promotes the expression of the target genes
Chunmei Fan   +6 more
wiley   +1 more source

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1 beta inhibition [PDF]

open access: yes, 2006
BACKGROUND:Neonatal-onset multisystem inflammatory disease is characterized by fever, urticarial rash, aseptic meningitis, deforming arthropathy, hearing loss, and mental retardation.
Adams, BS   +39 more
core  

Home - About - Disclaimer - Privacy